In a wide-ranging interview with Justin Petrone for GenomeWeb's 360Dx, Diagnostics for the Real World CEO and Chairman Dr Helen Lee and COO Craig Wisniewski talk exclusively about DRW's new assays – the SAMBA II SARS-CoV-2/Flu and SAMBA II SARS-CoV-2/RSV multiplex tests – plus the company's plans for the third-generation SAMBA platform, now in development.
Read the full article here (requires subscription to view).
